Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia.

The Israel Medical Association journal : IMAJ - 1 Aug 2012

Tohami Tali, Nagler Arnon, Amariglio Ninette

Abstract excerpt

Chronic myeloid leukemia (CML) is a clonal hematological disease that represents 15-20% of all adult leukemia cases. The study and treatment of CML has contributed pivotal advances to translational medicine and cancer therapy. The discovery that a single chromosomal abnormality, the Philadelphia (Ph) chromosome, is responsible for the etiology of this disease was a milestone for treating and understanding CML....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Laboratory Techniques
Share to Cytogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fusion Proteins, bcr-abl

Share to In Situ Hybridization, Fluorescence

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Monitoring, Physiologic

Share to Mutation

Source

Identifiers

PMID: 22977971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia.PMID 22977971Read ↗

Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolutionSemantic proximity Read ↗

The role of cytogenetics and molecular biology in the diagnosis, treatment and monitoring of patients with chronic myeloid leukemiaSemantic proximity Read ↗

Chronic Myeloid Leukemia: Current Application of Cytogenetics and Molecular Testing for Diagnosis and TreatmentSemantic proximity Read ↗

Chronic Myeloid Leukemia in 2007Semantic proximity Read ↗

[Recommendations from the GBMHM and the Fi-LMC for the diagnosis and management of chronic myeloid leukemia].Semantic proximity Read ↗

Evaluating treatment response of chronic myeloid leukemia: emerging science and technology.Semantic proximity Read ↗

Present and future of molecular monitoring in chronic myeloid leukaemia.Semantic proximity Read ↗

Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challengesSemantic proximity Read ↗

Best Practices in Chronic Myeloid Leukemia Monitoring and Management.Semantic proximity Read ↗

Current trends in molecular diagnostics of chronic myeloid leukemiaSemantic proximity Read ↗

Diagnostic work‐up of acute myeloid leukemiaSemantic proximity Read ↗

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.